October 2025 FDA Recall Drug by Mohamed Hagar (D-0396-2026 - Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).)

This Class I drug recall was voluntarily initiated by Mohamed Hagar on October 8, 2025 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda-fda analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0396-2026

Reason for Recall
Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
Initiated
10-08-2025
Reported
03-11-2026
Quantity
125 boxes

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0

Batch or Lot Expiration Information

Lot# ALL LOTS, exp 12/31/2027